Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,680 | N/A | 1,760 | N/A | N/A |
| Marketable Securities | 0 | N/A | 9,950 | N/A | N/A |
| Other current assets | 120 | 70 | 20 | 0 | 0 |
| TOTAL | $5,800 | $70 | $11,730 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 430 | 420 | 340 | N/A | N/A |
| Other Non-Current Assets | 10 | 10 | 60 | 0 | 0 |
| TOTAL | $440 | $430 | $400 | $N/A | $N/A |
| Total Assets | $6,250 | $500 | $12,140 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 620 | 390 | 50 | 0 | 0 |
| Accrued Expenses | 1,070 | 970 | 1,030 | N/A | N/A |
| Other current liabilities | 3,720 | 0 | 200 | N/A | N/A |
| TOTAL | $5,470 | $1,370 | $1,320 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $30 | $4 | $N/A | $N/A | $N/A |
| Total Liabilities | $5,510 | $1,374 | $1,320 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 2 | 1 | 1 | N/A | N/A |
| Retained earnings | -43,750 | N/A | -10,990 | N/A | N/A |
| Other shareholders' equity | 8 | 0 | -1 | 0 | 0 |
| TOTAL | $740 | $34,331 | $10,820 | $N/A | $N/A |
| Total Liabilities And Equity | $6,250 | $35,705 | $12,140 | $0 | $0 |